N-(nonanoyloxy)succinimide | 104943-23-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: N-(nonanoyloxy)succinimide
• 英文别名: nonanoic acid N-hydroxysuccinimide ester；2,5-Dioxopyrrolidin-1-yl nonanoate；(2,5-dioxopyrrolidin-1-yl) nonanoate
• CAS: 104943-23-9
• 化学式: C₁₃H₂₁NO₄
• 分子量: 255.314
• InChiKey: OVQHBHMRZFPJME-UHFFFAOYSA-N

物化性质

• 沸点：
  348.4±25.0 °C(Predicted)
• 密度：
  1.11±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  63.7
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温，惰性气氛

反应信息

• 作为反应物：
  描述：

  4-氨甲基苯甲酸 、 N-(nonanoyloxy)succinimide 以 乙酸乙酯 为溶剂， 反应 18.0h， 生成 N-(4-carboxybenzyl)nonamide
  参考文献：
  名称：

  Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region"

  摘要：

  A series of analogues of capsaicin, the pungent principle of chilli peppers, was synthesized and tested in assays for capsaicin-like agonism in vitro. The results of these assays were compared with activities in an acute nociceptive model and a correlation was observed which established that the results of these in vitro assays were predictive of analgesia. Using a modular approach the structure-activity profile of specific regions of capsaicin congeners was established using an in vitro assay measuring Ca-45(2+) uptake into neonatal rat dorsal root ganglia neurones. Substituted benzylnonanamides 2a-z and N-octyl-substituted phenylacetamides 4a-v were made to test the requirements for activity in the aromatic ''A-region'' of the molecule. Compounds with the natural substitution pattern (2b and 4c) and the corresponding catechols (2i and 4g) were the most potent, although the catechols were less potent in vivo. Other substitution patterns have reduced activity. These results have established stringent structural requirements for capsaicin-like activity in this part of the molecule.

  DOI：

  10.1021/jm00068a014
• 作为产物：
  描述：

  N-羟基丁二酰亚胺 、 壬酸 在 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 6.0h， 以96%的产率得到N-(nonanoyloxy)succinimide
  参考文献：
  名称：

  两种葡萄糖基神经酰胺合酶抑制剂组成的杂化结构的合成与评价

  摘要：

  葡萄糖基神经酰胺的代谢和涉及的酶已在药物化学中引起了极大的兴趣，因为源自葡萄糖基神经酰胺的糖脂水平的异常是导致一系列人类疾病（包括溶酶体贮积病，2型糖尿病和神经退行性疾病）的原因。因此，对参与糖基神经酰胺代谢的一种糖加工酶（糖基神经酰胺合酶（GCS），酸性糖基神经酰胺酶（GBA1）或中性糖基神经酰胺酶（GBA2））的选择性调节是一个有吸引力的研究目标。在这项研究中，我们采用了两种已建立的GCS抑制剂，一种基于脱氧野oji霉素，另一种基于神经酰胺类似物，并合并了特征性特征以获得杂化化合物。所得的39个化合物文库不包含新的GCS抑制剂。但是，有效的（200 nm）鉴定出对GBA2几乎没有活性的GBA1抑制剂，因此可以作为选择性GBA1调节剂作为进一步生物医学开发的先导。

  DOI：

  10.1002/cmdc.201500407

文献信息

• Synthetic libraries of tyrosine-derived bacterial metabolites
  作者：Savvas N. Georgiades、Jon Clardy

  DOI：10.1016/j.bmcl.2007.10.058

  日期：2008.5

  The preparation of a collection of 131 small molecules, reminiscent of families of long chain N-acyl tyrosines, enamides and enol esters that have been isolated from heterologous expression of environmental DNA (eDNA) in Escherichia coli, is reported. The synthetic libraries of N-acyl tyrosines and their 3-keto counterparts were prepared via solid-phase routes, whereas the enamides and enol esters

  据报道，制备了 131 个小分子的集合，让人联想到长链 N-酰基酪氨酸、烯酰胺和烯醇酯家族，这些分子是从大肠杆菌环境 DNA (eDNA) 的异源表达中分离出来的。N-酰基酪氨酸及其3-酮对应物的合成库是通过固相途径制备的，而烯酰胺和烯醇酯是在溶液相中合成的。
• A copper-catalysed amidation of aldehydes via N-hydroxysuccinimide ester formation
  作者：Monica Pilo、Andrea Porcheddu、Lidia De Luca

  DOI：10.1039/c3ob41440j

  日期：——

  A copper-catalysed oxidative amidation of aldehydes via N-hydroxysuccinimide ester formation is reported. The methodology employed to prepare amides directly from aldehydes has a very wide scope, is high yielding, and does not need dry conditions. This cross-coupling reaction appears to be simple and makes use of cheap, abundant and easily available reagents.

  据报道通过N-羟基琥珀酰亚胺酯形成的铜催化的醛的氧化酰胺化。直接从醛制备酰胺的方法学范围很广，产率高，并且不需要干燥条件。这种交叉偶联反应看起来很简单，并利用了廉价，丰富和容易获得的试剂。
• [EN] NOVEL CRYPTOPHYCIN COMPOUNDS AND CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE<br/>[FR] NOUVEAUX COMPOSÉS ET CONJUGUÉS DE CRYPTOPHYCINE, LEUR PRÉPARATION ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：SANOFI SA

  公开号：WO2017076998A1

  公开（公告）日：2017-05-11

  The present invention relates to cryptophycin compounds of formula (I). The invention also relates to cryptophycin payloads, to cryptophycin conjugates, to compositions containing them and to their therapeutic use, especially as anticancer agents. The invention also relates to the process for preparing these conjugates.

  本发明涉及公式（I）的隐藻素化合物。该发明还涉及隐藻素有效载荷、隐藻素偶联物、含有它们的组合物及其治疗用途，尤其是作为抗癌剂。该发明还涉及制备这些偶联物的过程。
• Synthesis and antipepsin activities of peptides having a valine or valylvaline moiety at the N-terminus.
  作者：KOZO OKADA、YOTARO KUROSAWA、SOTOO NAGAI

  DOI：10.1248/cpb.27.2163

  日期：——

  A series of peptides having a valine or valyvaline moiety at the N-terminus, 1-13, was prepared and their antipepsin activities were tested. All of the peptides possessing an N-acyl-Val-Val moiety, except one, showed some inhibitory activity against pepsin, while compounds lacking N-acyl-Val-Val showed no inhibition even at a concentration of 50 μg/ml. Compound 12, a pepstatin analog, in which a tyrosine residue is present instead of AHMHA of pepstatins, was the most potent inhibitor among the synthetic peptides, but its activity was markedly lower than that of pepstatin A. Compounds 10, 12, and 13 showed neither agonistic nor antagonistic effects on pepstatin A, suggesting major differences in binding abilities of the synthetic peptides and of pepstatin A to the enzyme. The importance of the AHMHA residue of pepstatins in relation to the inhibitory activity is discussed.

  合成了一系列在N端具有缬氨酸或二缬氨酸基团的肽，编号为1-13，并测试了它们的抗胃蛋白酶活性。所有具有N-酰基-缬-缬二肽基团的肽，除了一个，显示出一定的抑制胃蛋白酶活性，而缺乏N-酰基-缬-缬二肽基团的化合物即使在50μg/ml的浓度下也没有抑制作用。化合物12是pepstatin的类似物，其中的酪氨酸残基替代了pepstatins中的AHMHA，是合成肽中抑制作用最强的，但其活性明显低于pepstatin A。化合物10、12和13对pepstatin A既没有激动作用也没有拮抗作用，这表明合成肽和pepstatin A与酶的结合能力存在显著差异。文中讨论了pepstatins中AHMHA残基对抑制活性的重要性。
• Synthetic ceramide analogues as skin permeation enhancers: structure–Activity relationships
  作者：Kateřina Vávrová、Alexandr Hrabálek、Pavel Doležal、Lucie Šámalová、Karel Palát、Jarmila Zbytovská、Tomáš Holas、Jana Klimentová

  DOI：10.1016/j.bmc.2003.09.034

  日期：2003.12

  The study presents new information about the structure-activity relationships of the skin permeation enhancers. A series of ceramide analogues including eight different polar head groups and six different chain lengths was synthesised. The compounds were evaluated as permeation enhancers in vitro using porcine skin. The physico-chemical parameters of the tested compounds obtained by computer modelling were used to evaluate, by multiple linear regression, the enhancement ratios (ERs) of the compounds. The regression analysis suggests that the hydrogen bonding ability of the compounds is inversely related to the ER values and that the molecular size and lipophilicity must be well balanced. In the studied enhancers having the same chain length, the enhancement activity is dependent only on their permeability coefficients. This finding confirms the Warner's hypothesis that the polar head of an enhancer is responsible for the permeation and anchoring of the molecule into the stratum corneum lipids and that it does not influence the mechanism of action. For the specific action of enhancers, that is disordering of the intercellular lipid packing, the length of the hydrophobic chain(s) and not the lipophilicity is important. Furthermore, the examination of the FTIR spectra indicated that the most active substances possess the most ordered chains. The described relationships could bring more rational approaches in designing new potent enhancers for transdermal formulations. (C) 2003 Elsevier Ltd. All rights reserved.